ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,555.74
      -0.16%
      US Tech 100
      19,107.20
      -1.02%
      Dow Jones
      40,358.09
      -0.14%
      Brent Oil
      80.575
      -0.25%
      Bitcoin
      65,944.11
      0.03%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Castle Biosciences Inc (CSTL)

      7. Castle Biosciences Inc (CSTL) Financials

      Castle Biosciences Inc

      Castle Biosciences Inc (CSTL)

      NASDAQ
      20.29
      0.39
      (1.96%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      20.29
      0.01
      (0.05%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Castle Biosciences Inc Financial Summary

      The current CSTL market cap is 560.15M. The company's latest EPS is USD -2.0816 and P/E is -9.74.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 42.04M50.14M61.49M66.12M72.97M
      Operating Income -31.52M-21.16M-9.64M-5.66M-5.47M
      Net Income -29.2M-18.78M-6.91M-2.58M-2.53M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 51.87M64.53M94.09M155.33M219.79M
      Operating Income 7.33M-6.54M-40.08M-72.86M-67.98M
      Net Income 2.99M-10.28M-31.29M-67.14M-57.47M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 426.89M425.4M436.02M453.34M458.51M
      Total Liabilities 41.74M46.63M50.24M62.07M56.05M
      Total Equity 385.15M378.77M385.78M391.27M402.46M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 119.75M439.33M462.57M447.33M453.34M
      Total Liabilities 34.63M23.64M50.83M48.18M62.07M
      Total Equity 85.11M415.69M411.74M399.15M391.27M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -25.44M-29.23M-24.21M-5.63M-6.84M
      Investing 16.58M1.2M-8.51M-16.18M-19.7M
      Financing 728k954k999k-2.3M10.64M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 7.02M9.87M-18.98M-41.66M-5.63M
      Investing -937k-4.75M-66.66M-166.55M-16.18M
      Financing 88.29M305.89M5.42M1.52M-2.3M

      Stats and Ratios

      Market Cap 560.15M
      Price to Earnings Ratio -9.74
      Price to Sales Ratio 2.55
      Price to Cash Ratio 5.66
      Price to Book Ratio 1.43
      Dividend Yield -

      Share Statistics

      Shares Outstanding 27.61M
      Average Volume (1 week) 384.09k
      Average Volume (1 Month) 397.96k
      52 Week Change 21.50%
      52 Week High 25.91
      52 Week Low 12.07
      Spread (Intraday) 3.4 (15.89%)

      Company Info

      Company Name Castle Biosciences Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.castlebiosciences.com
      Industry medical laboratories (8071)